The initiation of an SGLT2 inhibitor or a GLP-1 receptor agonist compared with a DPP-IV inhibitor was associated with lower CV events and death without increasing the overall incidence rate of severe safety outcomes, regardless of frailty status, Elisabetta Patorno, MD, DrPH , associate professor of medicine at Harvard Medical School and associate epidemiologist in the division of pharmacoepidemiology and pharmacoeconomics at Brigham and Womens Hospital, and colleagues wrote
Sermorelin improves lean muscle and bone density but has limited weight loss data as monotherapy
Effects of dietary glutathione supplementation onimmunity, antioxidant capacity and relievinghepatopancreatic injury of Chinese mitten crab,Eriocheir sinensis
Recalls & Warnings April 11, 2008 Twelve Dietary Herbal Supplements Recalled -- Possible Health Risk Associated with Ephedra, Aristolochic Acid and Human Placenta On April 10, 2008, the FDA posted a recall notice issued the same day from Herbal Science International, Inc